Ube (4208) · RiskMitigated
Risk of impairment of fixed assets due to deterioration in the business environment
First written in FY2016. 10 of 25 entries say "Worsened", first in FY2018. Latest entry: FY2026.
25entries
11years
1from disclosures
How it moved
Same theme, other companies
Impairment of manufacturing facilities due to deteriorating profitability across multiple chemical businessesA theme 2 companies write about · 3 as a headwind · 0 as a tailwind
Ube moved to the "Worse" side of this theme in 2016.
0 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2026MitigatedAnnual report
「For the consolidated fiscal year, the Company recognized impairment losses on fixed assets of ¥2,699 million.」
Impairment losses on fixed assets decreased substantially from ¥29.079 billion in the previous fiscal year to ¥2.699 billion. However, impairment occurred in ammonia and caprolactam, polyimide, Thai caprolactam and nylon, and other businesses. - 2026-05-13MitigatedEarnings
「前期にアンモニア・カプロラクタム・ナイロンポリマーの事業構造改革を決定したことに伴う特別損失が、当期は発生しなかったことにより、当期の特別損失は前期に比べ297億７千８百万円減少し、71億６百万円となりました。」
固定資産減損損失は前期の290億7,900万円から26億9,900万円へ減少しました。 - FY2026-H1WorsenedAnnual report
「Impairment losses 21 1,471」
Impairment losses for the current interim consolidated period amounted to ¥1.471 billion, a substantial increase from ¥21 million in the same period of the previous fiscal year. - FY2025WorsenedAnnual report
「For the consolidated fiscal year, the Company recognized impairment losses on fixed assets of ¥29,079 million.」
Impairment losses on fixed assets increased substantially from ¥353 million in the previous fiscal year to ¥29.079 billion, indicating that the impairment risk associated with a deterioration in the business environment and business withdrawals expanded in actual results. - FY2025-H1MitigatedAnnual report
「Impairment losses 122 21」
Impairment losses for the current interim consolidated period were ¥21 million, down from ¥122 million in the same period of the previous fiscal year. Impairment of fixed assets occurred, but decreased in scale. - FY2024MitigatedAnnual report
「For the current fiscal year, the Company recorded ¥353 million in impairment losses on fixed assets.」
Impairment of fixed assets continued, but decreased from ¥1,350 million in the previous fiscal year to ¥353 million. - FY2024-Q3MitigatedAnnual report
「Impairment losses 766 142」
Cumulative impairment losses on fixed assets for the third quarter were ¥142 million, down from ¥766 million in the same period of the previous fiscal year. Impairment of fixed assets occurred, but decreased in scale year on year. - FY2024-Q2MitigatedAnnual report
「Impairment losses 530 122」
Cumulative impairment losses on fixed assets for the second quarter amounted to ¥122 million, down from ¥530 million in the same period of the previous fiscal year. Impairment of fixed assets occurred, but decreased in scale year on year. - FY2024-Q1MaterialisedAnnual report
「Impairment losses － 78」
Impairment losses on fixed assets of ¥78 million were recorded for the cumulative first quarter period, indicating that impairment continued to occur in actual results. - FY2023WorsenedAnnual report
「For the current fiscal year, the Company recorded ¥1,350 million in impairment losses on fixed assets.」
Impairment losses on fixed assets increased from ¥771 million in the previous fiscal year to ¥1.35 billion. Impairment occurred on facilities following decisions to withdraw and on facilities with no expected future use. - FY2023-Q3WorsenedAnnual report
「Impairment losses 100 766」
Cumulative impairment losses on fixed assets for the third quarter amounted to ¥766 million, up from ¥100 million in the same period of the previous fiscal year. The fixed-asset impairment risk expanded in actual results. - FY2023-Q2WorsenedAnnual report
「Impairment losses － 530」
The Company recorded ¥530 million in impairment losses during the cumulative second quarter period, resulting in impairment of fixed assets that had not been recorded in the same period of the previous fiscal year. - FY2022-Q3WorsenedAnnual report
「Impairment losses 15 100」
Cumulative impairment losses for the third quarter amounted to ¥100 million, up from ¥15 million in the same period of the previous fiscal year. The fixed-asset impairment risk expanded again in actual results. - FY2022-Q2MitigatedAnnual report
「Impairment losses 15 －」
No impairment losses were recorded for the cumulative second quarter period, down from ¥15 million in the same period of the previous fiscal year. The impact of the fixed-asset impairment risk on actual results decreased. - FY2021MitigatedAnnual report
「For the current fiscal year, the Company recorded ¥55 million in impairment losses on fixed assets.」
Impairment of fixed assets occurred, but decreased substantially from ¥5.236 billion in the previous fiscal year to ¥55 million. - FY2021-Q2MitigatedAnnual report
「Impairment losses 180 15」
Cumulative impairment losses for the second quarter were ¥15 million, down from ¥180 million in the same period of the previous fiscal year. Impairment of fixed assets continued to occur, but decreased in scale. - FY2020-Q3WorsenedAnnual report
「Impairment losses 4,797」
Cumulative impairment losses for the third quarter amounted to ¥4.797 billion, a substantial increase from ¥154 million in the same period of the previous fiscal year. The main factor cited was ¥4.617 billion in impairment related to the transfer of the golf course business. - FY2020-Q2WorsenedAnnual report
「Impairment loss 180」
Impairment losses on fixed assets for the cumulative second quarter period amounted to ¥180 million, up from ¥154 million in the same period of the previous fiscal year. The risk of impairment of fixed assets continued to materialize and increased in scale. - FY2019MitigatedAnnual report
「For the current fiscal year, the Company recorded ¥882 million in impairment losses on fixed assets.」
Impairment of fixed assets continued, but decreased from ¥3.667 billion in the previous fiscal year to ¥882 million. Impairment associated with the withdrawal from facilities for organometallic compounds and other operations remains. - FY2019-Q3RestatedAnnual report
「Impairment losses 154」
Cumulative impairment losses for the third quarter were ¥154 million, unchanged from the cumulative amount reported for the previous quarter, reconfirming the occurrence of impairment of fixed assets. - FY2019-Q2WorsenedAnnual report
「Impairment losses 154」
Cumulative impairment losses for the second quarter amounted to ¥154 million, up from ¥71 million in the same period of the previous fiscal year. Impairment of fixed assets continued to occur in actual results. - FY2019-Q1MaterialisedAnnual report
「Impairment losses 95」
The Company recorded ¥95 million in impairment losses in the first quarter, confirming that impairment of fixed assets continued to occur in actual results. - FY2018WorsenedAnnual report
「For the current fiscal year, the Company recorded ¥3.667 billion in impairment losses on fixed assets.」
Impairment losses on fixed assets amounted to ¥3.667 billion, up from ¥586 million in the previous fiscal year. Impairment occurred on idle assets, assets scheduled for disposal, withdrawn businesses and dissolved companies. - FY2018-Q3MaterialisedAnnual report
「Impairment losses 71」
Impairment losses of ¥71 million were recorded for the cumulative third quarter period, confirming that impairment of fixed assets continued to occur in actual results. - FY2016MaterialisedAnnual report
「For the current fiscal year, the Company recorded ¥9.08 billion in impairment losses on fixed assets.」
Impairment losses due to deteriorating profitability occurred at facilities for polyimide, electrolytes, fine materials and other products.